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DD ACE gene polymorphism is associated with increased
coronary artery endothelial dysfunction: the PREFACE trial
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Endothelial dysfunction is an early event in atherogenesisand is associated with the propensity to cause futurecardiovascular events. The amelioration of endothelial
dysfunction has been a research target for some years now,
and success has been reported with, for example, the
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reduct-
ase inhibitors. Research has also identified the homozygous
deletion (DD) subset of the angiotensin converting enzyme
(ACE) insertion(I)/deletion(D) polymorphism to be associ-
ated with deteriorated endothelial function. The results, how-
ever, are conflicting. In a substudy of the PREFACE
(pravastatin-related effects following angioplasty on coronary
endothelium) trial1 we assessed ACE polymorphism, coronary
endothelial function, and the influence of the HMG-CoA
reductase inhibitor pravastatin.
METHODS
PREFACE1 was a randomised, double blinded, placebo
controlled, multicentre study designed to assess the effect of
three months of treatment with pravastatin (40 mg, once
daily) on the endothelial function of native and dilated coron-
ary arteries in non-smoking, non-hypercholesterolaemic
patients.
Coronary endothelium dependent vasomotion at three
months was assessed by serial, two minute, intracoronary
infusions of acetylcholine with the final intracoronary
concentrations estimated to be 10-8, 10-7, and 10-6 M. Hereafter
endothelium independent vasomotion was assessed by the
infusion of glyceryl trinitrate at 40 µg per minute for two
minutes. Within 15 seconds of each infusion, coronary arteri-
ography was performed with a non-ionic contrast medium
and a power injector.
Quantitative coronary analysis was performed at the Heart-
core angiographic laboratory (Leiden, The Netherlands) in a
blinded fashion. Target segments for analysis were the dilated
segment and an angiographically normal segment. Segment
responses were calculated as the percentage change in the
mean segment diameter after infusion relative to the mean
segment diameter at baseline.
The ACE genotyping was performed according to a modified
procedure from Rigat and associates.2
Vasomotion measurements were compared between geno-
types by mixed model analysis of variance (ANOVA) with the
ACE genotype and acetylcholine infusion dose as fixed factors
and the patient number as the random factor. The factors of
the model were expanded with treatment and the interaction
factor treatment/genotype for analysis of these factors. We also
performed a pooled analyses of DD versus ID/II as the
literature demonstrates that the DD polymorphism is most
often associated with deleterious effects, while the ID/II geno-
type subsets show similar results.
RESULTS
Fifty two patients (47 men, 5 women) were included in this
substudy. The groups of patients divided according to ACE
genotype subsets (II, ID, DD) were similar with respect to age,
blood pressure, serum lipids, and history of cardiovascular
events. The only discernable difference between the groups
was the number of patients randomised to pravastatin, which
was significantly higher in the ID group—pravastatin/placebo:
II (3/7), ID (21/7), DD (6/8).
The luminal parameters of both dilated and normal
segments at baseline and after glyceryl trinitrate infusion
were similar between the genotype subsets. We found that the
DD genotype was associated with a significant deteriorated
endothelial function as compared to the other genotypes in
both the dilated (p = 0.03) and the normal segment groups
(p = 0.01). Pooled analyses of DD subset versus the ID/II sub-
set demonstrated increased significance in both the dilated
(p = 0.003) and the normal coronary artery segment groups
(p = 0.008) (fig 1). When pravastatin treatment was included
in the analyses in the dilated segment group a significant
effect was present (p = 0.04). When the data are pooled as
II/ID versus DD an increased significance of the pravastatin
effect is observed (p = 0.02).
DISCUSSION
Perticone and colleagues used forearm strain gauge plethys-
mography to assess endothelial function in patients with
never-treated hypertension.3 They observed an association
between the DD genotype and endothelial dysfunction. In the
normotensive control group, however, no association was
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Figure 1 ACE genotype and change in mean segment diameter for
normal and dilated coronary segments. DD subset versus the ID/II
subsets demonstrates a significant difference in both the dilated (p =
0.003) and the normal coronary artery segment groups (p = 0.008).
557
www.heartjnl.com
present. This led them to the conclusion that the ACE
polymorphism did not provide the most important component
of endothelial dysfunction. Contrary to these results were the
findings of Butler and colleagues4 who demonstrated an
association between the insertion/deletion and endothelial
function in healthy young men.
To our knowledge there are no previous reports on the rela-
tion between ACE polymorphism and in vivo epicardial
coronary endothelial function. Our results agree with the
forearm findings of Butler and colleagues.4 We found an
association between the DD genotype and deteriorated
endothelial function in both normal and dilated coronary
artery segments in patients with few risk factors. The
dominant influence of the DD genotype is demonstrated by
the fact that it is also present in the dilated segments. The
endothelium of these segments has been exposed for only two
months to factors like hypertension, which exerts its effect in
the long term. To our knowledge there are also no previous
reports on the relation between ACE genotype, the use of stat-
ins, and coronary endothelial function. We found a significant
beneficial effect of pravastatin in the DD subset of the dilated
segment group.
In summary, this study demonstrates that the DD genotype
is associated with blunted endothelial function of epicardial
coronary arteries. Furthermore an ameliorating effect of prav-
astatin in patients with the DD genotype in the dilated coron-
ary artery was found. Although the PREFACE trial was not
specifically designed to address the issue of ACE polymor-
phism effects on endothelial function, we think the results
may be of clinical importance and warrants further research.
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Prolonged sinus arrest after coronary artery spasm
Coronary artery spasm has been proposed as a definitecause of vasospastic angina and as a contributor toother acute cardiac events, including unstable angina,
acute myocardial infarction, and sudden cardiac death. It has
also been demonstrated that silent ischaemia caused by
coronary artery spasm could initiate potentially fatal arrhyth-
mias in patients without flow limiting structural coronary
artery lesions. We report a case of prolonged sinus arrest after
an attack of coronary artery spasm.
A 50 year old woman presented with recurrent spontaneous
chest pain that usually occurred in the morning. She had been
diagnosed as having hypertension two months previously
without taking any medication. Resting ECG showed normal
sinus rhythm without ST-T wave change (panel A). Treadmill
exercise test with Bruce protocol showed no significant ST
change with good exercise tolerance. Holter monitoring was
applied, during which the patient had severe chest pain
followed by syncope at midnight. Holter monitoring during
chest pain showed pronounced ST segment elevation (panel
B) followed by bradycardia (panel C). After normalisation of
ST segment elevation, prolonged (28 seconds) sinus arrest fol-
lowed (panel D), which was the cause of her syncope. Coron-
ary angiography showed no significant luminal narrowing.
The patient was treated with a calcium channel blocker and
nitrates, with a subsequent uneventful clinical course.
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